| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000236869.1 |
Palbociclib |
Chronic Lymphocytic Leukemia |
0.005162196 |
Resistant |
| ENSG00000236869.1 |
Palbociclib |
Pancreatic adenocarcinoma |
0.020533542 |
Resistant |
| ENSG00000236869.1 |
Palbociclib |
Sarcoma |
0.01788114 |
Resistant |
| ENSG00000236869.1 |
Palbociclib |
Bladder urothelial carcinoma |
0.048959524 |
Sensitive |
